Research Partnership between HistoIndex and the Institute of Molecular and Cell Biology (IMCB), A*STAR
HistoIndex is expanding its existing pre-clinical and clinical applications to include accurate diagnosis of more diseases, ranging from various types of cancer, endocrine diseases, cutaneous conditions, eye diseases and disorders, intestinal diseases, neurological disorders, heart disorders and even infectious diseases.
This collaboration involves:-
1. Advanced Molecular Pathology Laboratory (AMPL) - where histology processing and pathology evaluation with existing stain-based imaging approach will take place; &
2. Central Imaging Facility (CIF) - which will perform image processing, 2D/3D analysis and accompanied bioinformatics support of the acquired stain-free images from Genesis®200.